Free Trial

Amplify Treatments, Testing and Advancements ETF (GERM) News Today

Amplify Treatments, Testing and Advancements ETF logo
$19.16 0.00 (0.00%)
As of 01/17/2025
Amplia Therapeutics Advances Cancer Drug Trial
Amplify ETFs to Liquidate Three ETFs
THNR Amplify Weight Loss Drug & Treatment ETF
ETFMG Treatments Testing and Advancements ETF
GERM ETFMG Treatments, Testing and Advancements ETF
Lactose Intolerance Treatment Market Growth by 2031
How to invest in the future of vaccines
SogoTrade Review
5 Must-Watch ETF Charts of Q2 Earnings
Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter.

GERM Media Mentions By Week

GERM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GERM
News Sentiment

0.00

0.40

Average

News Sentiment

GERM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GERM Articles
This Week

0

0

GERM Articles
Average Week

Get Amplify Treatments, Testing and Advancements ETF News Delivered to You Automatically

Sign up to receive the latest news and ratings for GERM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSEARCA:GERM) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners